AI assistant
Galecto, Inc. — Director's Dealing 2025
Nov 18, 2025
35406_dirs_2025-11-17_57d4e54e-87d8-45c3-9f44-cc37e98cd20b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Galecto, Inc. (GLTO)
CIK: 0001800315
Period of Report: 2025-11-10
Reporting Person: Fairmount Funds Management LLC (N/A)
Reporting Person: Fairmount Healthcare Fund II L.P. (N/A)
Reporting Person: Fairmount Healthcare Co-Invest V L.P. (N/A)
Reporting Person: Kiselak Tomas (N/A)
Reporting Person: Harwin Peter Evan (N/A)
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Series B Preferred Stock | $ | Common Stock (16366000) | Indirect | ||
| Series C Preferred Stock | $ | Common Stock (6957000) | Indirect | ||
| Series C Preferred Stock | $ | Common Stock (3478000) | Indirect |
Footnotes
F1: Following stockholder approval of the conversion of Series B Preferred Stock into shares of Common Stock, each share of Series B Preferred Stock will be convertible, at the option of the holder, into 1,000 shares of Common Stock, subject to certain limitations. Fairmount (as defined below) may not convert such shares if Fairmount, together with its affiliates, would beneficially own more than 19.99% of the number of shares of Common Stock outstanding immediately after giving effect to such conversion.
F2: Fairmount Funds Management LLC ("Fairmount") is the investment manager for Fairmount Healthcare Fund II L.P. and Fairmount Healthcare Co-Invest V L.P. Peter Harwin and Tomas Kiselak are the managers of Fairmount. Fairmount, Mr. Harwin, and Mr. Kiselak disclaim beneficial ownership of any of the reported securities, except to the extent of their pecuniary interest therein.
F3: Following stockholder approval of the conversion of Series C Preferred Stock into shares of Common Stock, each share of Series C Preferred Stock will automatically convert into 1,000 shares of Common Stock, subject to certain limitations. Fairmount may not convert such shares if Fairmount, together with its affiliates, would beneficially own more than 19.99% of the number of shares of Common Stock outstanding immediately after giving effect to such conversion.